Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type (2014-2025)
1.4.2 HEPtune® Technology
1.4.3 Intravail® Technology
1.4.4 RapidMist™
1.4.5 TheraKine Technology
1.4.6 Arestat™ Technology
1.4.7 DelSiTech™ Silica Matrix
1.4.8 ImSus® Technology
1.4.9 PLEX™ Technology
1.4.10 ENHANZE® Technology
1.5 Market by Application
1.5.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2019-2025)
1.5.2 Delivery of Protein
1.5.3 Delivery of Nucleic Acids
1.5.4 Delivery Antibody
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size
2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Trends by Regions
2.2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (2019-2025)
2.2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by by Players
3.1.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by by Players (2014-2019)
3.1.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by by Players (2014-2019)
3.1.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio (CR5 and HHI)
3.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players Head office and Area Served
3.3 Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product/Solution/Service
3.4 Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2014-2019)
4.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2014-2019)
5 North America
5.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
5.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in North America
5.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
5.4 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
6 Europe
6.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
6.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Europe
6.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
6.4 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
7 China
7.1 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
7.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in China
7.3 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
7.4 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
8 Japan
8.1 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
8.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Japan
8.3 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
8.4 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
9.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Southeast Asia
9.3 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
9.4 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
10 India
10.1 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
10.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in India
10.3 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
10.4 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
11 Central & South America
11.1 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
11.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Central & South America
11.3 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
11.4 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
12 International Players Profiles
12.1 Aphios
12.1.1 Aphios Company Details
12.1.2 Company Description and Business Overview
12.1.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.1.4 Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019))
12.1.5 Aphios Recent Development
12.2 Arbutus Biopharma
12.2.1 Arbutus Biopharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.2.4 Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.2.5 Arbutus Biopharma Recent Development
12.3 Camurus
12.3.1 Camurus Company Details
12.3.2 Company Description and Business Overview
12.3.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.3.4 Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.3.5 Camurus Recent Development
12.4 ConjuChem
12.4.1 ConjuChem Company Details
12.4.2 Company Description and Business Overview
12.4.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.4.4 ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.4.5 ConjuChem Recent Development
12.5 InnoCore Pharmaceuticals
12.5.1 InnoCore Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.5.4 InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.5.5 InnoCore Pharmaceuticals Recent Development
12.6 LATITUDE Pharmaceuticals
12.6.1 LATITUDE Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.6.4 LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.6.5 LATITUDE Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Aphios、Arbutus Biopharma、Camurus、ConjuChem、InnoCore Pharmaceuticals、LATITUDE Pharmaceuticals
【免責事項】
https://www.globalresearch.jp/disclaimer